文献速递生殖医学产科

使用机器学习方法预测接受辅助生殖技术女性的妊娠相关并发症

Prediction of pregnancy-related complications in women undergoing assisted reproduction, using machine learning methods.
PubMed 文献 · Fertil Steril · 2024-02-17

基于瑞典全国注册登记的前瞻性队列数据,纳入2008至2016年间前三个辅助生殖技术(ART)治疗周期内分娩的14,732名初产妇,利用机器学习方法构建预测子痫前期、胎盘并发症和产后出血的模型。结果显示,治疗前模型预测性能最高约60%至66%,加入治疗信息后仅轻微提升约1%至5%;人口学、病史和ART治疗信息不足以自信预测严重妊娠并发症。

要点

  • 首个ART周期治疗前模型预测子痫前期、胎盘并发症和产后出血的性能最高分别为66%、66%和60%。
  • 加入治疗特征后预测性能仅提升约1%至5%,后续周期预测性能类似提升约1%至5%。
  • 年龄、居住地区、不孕诊断和胚胎移植类型(新鲜或冷冻)是后续周期中重要且一致的预测因素。

核心结论

  • 联合使用人口学、病史和ART治疗信息不足以自信预测ART受孕女性的严重妊娠并发症。
  • 未来需要研究孕期额外纵向随访能否改善预测以促进临床方案开发。

研究设计与样本

  • 全国注册登记的前瞻性数据队列研究,数据来自瑞典国家注册和全国质量IVF注册。
  • 纳入2008至2016年间前三个ART治疗周期内分娩的所有初产妇,共14,732名,第一、第二、第三周期分娩人数分别为7,302、4,688和2,742名,分娩率分别为24.1%、23.8%和22.0%。
  • 使用逻辑回归、决策树、朴素贝叶斯、支持向量机、随机森林和梯度提升等多种算法构建预测模型,以C统计量评估性能,并采用嵌套交叉验证进行模型选择和超参数调优。

主要发现

  • 第一周期治疗前预测子痫前期、胎盘并发症和产后出血的性能最高分别为66%、66%和60%。
  • 加入治疗后特征后预测性能轻微改善约1%至5%,后续周期预测性能也类似改善约1%至5%。
  • 后续周期(第二和第三周期)中重要且一致的预测因素包括年龄、居住地区、不孕诊断和胚胎移植类型(新鲜或冷冻)。
  • 体重指数是子痫前期的重要预测因素,对胎盘并发症也有影响,但对产后出血无影响。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 联合使用人口学、病史和ART治疗信息不足以自信预测严重妊娠并发症。
  • 未来需要研究孕期额外纵向随访能否改善预测以促进临床方案开发。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To use machine learning methods to develop prediction models of pregnancy complications in women who conceived with assisted reproductive techniques (ART). DESIGN: A nation-wide register-based cohort study with prospectively collected data. SETTING: Swedish national registers and nationwide quality IVF register. PATIENT(S): all nulliparous women who achieved birth within the first 3 ART treatment cycles between 2008 and 2016 in Sweden. INTERVENTION(S): Characteristics before the use of ART, such as demographics and medical history, were considered potential predictors in the development of before treatment prediction models. ART treatment details were further included in after treatment prediction models. MAIN OUTCOME MEASURE(S): Potential diagnoses of preeclampsia, placental complications (previa, accreta, and abruption), and postpartum hemorrhage were identified using the International Classification of Diseases recorded in the Swedish Medical Birth and Patient registers, respectively. Multiple prediction model algorithms were performed and compared for each outcome and treatment cycle, including logistic regression, decision tree model, naïve Bayes classification, support vector machine, random forest, and gradient boosting. The performance of each model was assessed with C statistic, and nested cross-validation was used to aid model selection and hyperparameter tuning. RESULT(S): A total of 14,732 women gave birth after the first (N = 7,302), second (N = 4,688), or third (N = 2,742) ART cycle, representing birth rates of 24.1%, 23.8%, and 22.0%. Overall prediction performance did not vary much across the different methods used. In the first cycle, the before treatment prediction performance was at best 66%, 66%, and 60% for preeclampsia, placental complications, and postpartum hemorrhage, respectively. Inclusion of after treatment characteristics conferred slight improvement (approximately 1%-5%), as did prediction in later cycles (approximately 1%-5%). The top influential and consistent predictors included age, region of residence, infertility diagnosis, and type of embryo transfer (fresh or frozen) in the later (2nd and 3rd) cycles. Body mass index was a top predictor of preeclampsia and was also influential for placental complications but not for postpartum hemorrhage. CONCLUSION(S): The combined use of demographics, medical history, and ART treatment information was not enough to confidently predict serious pregnancy complications in women who conceived with ART. Future studies are needed to assess if additional longitudinal follow-up during pregnancy can improve the prediction to allow clinical protocol development.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Wang C, Johansson ALV, Nyberg C, et al. Prediction of pregnancy-related complications in women undergoing assisted reproduction, using machine learning methods. Fertil Steril. 2024. PMID: 38373676. doi:10.1016/j.fertnstert.2024.02.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。